Aurorium LLC's Complete FDA Record

FDA action counts

Enforcement history

On 2026-03-06, Argus HQ recorded an FDA Form 483 inspection citation for Aurorium LLC, rated "high" severity in Argus HQ's classification: Aurorium LLC -- FDA 483: 1 observation (2026-03-06). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Aurorium LLC has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Frequently asked questions

How many FDA actions does Argus HQ track for Aurorium LLC?

1 total: 0 warning letters, 0 recalls, 0 approval records, and 1 Form 483 inspection citation.

What is the most recent FDA action on file for Aurorium LLC?

March 6, 2026. Argus HQ ingests new FDA enforcement records daily.

Is this FDA enforcement data for Aurorium LLC official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has Aurorium LLC had?

Argus HQ has recorded 1 FDA events for Aurorium LLC: 0 warning letters, 0 recalls, 0 approvals, and 1 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Related enforcement actions

• Aurorium LLC -- FDA 483: 1 observation (2026-03-06) →

Compare with

• Aurorium LLC vs Medline Industries, LP
• Aurorium LLC vs ARROW INTERNATIONAL, LLC
• Aurorium LLC vs Stryker Sustainability Solutions
• Aurorium LLC vs Guardian Drug Co. Inc.
• Aurorium LLC vs B BRAUN MEDICAL INC